Medical Properties Trust Inc (NYSE:MPW)’s traded shares stood at 1.04 million during the latest session, with the company’s beta value hitting 1.33. At the last check today, the stock’s price was $4.34, to imply a decrease of -1.48% or -$0.06 in intraday trading. The MPW share’s 52-week high remains $6.55, putting it -50.92% down since that peak but still an impressive 32.72% since price per share fell to its 52-week low of $2.92. The company has a valuation of $2.60B, with an average of 13.18 million shares in intraday trading volume over the past 10 days and average of 11.99 million shares over the past 3 months.

Analysts have given a consensus recommendation of Hold for Medical Properties Trust Inc (MPW), translating to a mean rating of 3.45. Of 9 analyst(s) looking at the stock, 1 analyst(s) give MPW a Sell rating. 0 of those analysts rate the stock as Overweight while 5 advise Hold as 3 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at 0.1.

Medical Properties Trust Inc (NYSE:MPW) trade information

After registering a -1.48% downside in the latest session, Medical Properties Trust Inc (MPW) has traded red over the past five days. The 5-day price performance for the stock is -4.52%, and -8.35% over 30 days. With these gigs, the year-to-date price performance is -11.71%. Short interest in Medical Properties Trust Inc (NYSE:MPW) saw shorts transact 222.18 million shares and set a 22.4 days time to cover.

The extremes give us $4 and $27 for target low and target high price respectively. As such, MPW has been trading -522.12% off suggested target high and 7.83% from its likely low.

Medical Properties Trust Inc (MPW) estimates and forecasts

Looking at statistics comparing Medical Properties Trust Inc share performance against respective industry, we note that the company has underperformed competitors. Medical Properties Trust Inc (MPW) shares are -15.33% down over the last 6 months, with its year-to-date growth rate lower than industry average at -49.06% against -3.70%. Revenue is forecast to grow 116.07% this quarter before jumping 250.12% for the next one. The rating firms project that company’s revenue will grow 15.72% compared to the previous financial year.

Revenue forecast for the current quarter as set by 4 analysts is 228.85M. Meanwhile, for the current quarter, a total of 3 analyst(s) estimate revenue growth to 228.7M.Earnings reports from the last fiscal year show that sales brought in -122.38M and 271.32M respectively in the corresponding quarters. In this case, analysts estimate current quarter sales to rise 286.99% before dropping -15.71% in the following quarter.

MPW Dividends

Medical Properties Trust Inc has its next earnings report out on 2025-Feb-19. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too. Medical Properties Trust Inc has a forward dividend ratio of 0.53, with the share yield ticking at 12.23% to continue the rising pattern observed over the past year. The company’s average dividend yield trailing the past 5-year period is 9.43%.

Medical Properties Trust Inc (NYSE:MPW)’s Major holders

Medical Properties Trust Inc insiders hold 13.37% of total outstanding shares, with institutional holders owning 65.25% of the shares at 75.32% float percentage. In total, 65.25% institutions holds shares in the company, led by BLACKROCK INC.. As of 2024-06-30, the company held over 92.15 million shares (or 15.3511% of shares), all amounting to roughly $397.18 million.

The next major institution holding the largest number of shares is VANGUARD GROUP INC with 92.1 million shares, or about 15.3429% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $396.97 million.